Company Filing History:
Years Active: 2025
Title: Jagatraj Singh: Innovator in Diabetes and Obesity Treatment
Introduction
Jagatraj Singh is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for diabetes and obesity. His innovative work focuses on peptide analog formulations that have the potential to improve patient outcomes.
Latest Patents
Jagatraj Singh holds a patent for "Oxyntomodulin peptide analog formulations." This invention relates to GLP-1 and/or glucagon receptor agonists, specifically oxyntomodulin peptide analogs. The patent covers pharmaceutically acceptable salts, formulations comprising these compounds, and their uses in treating diabetes and associated diseases or disorders. He has 1 patent to his name.
Career Highlights
Jagatraj Singh is currently employed at Eirgen Pharma Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in peptide formulations has positioned him as a valuable asset in the development of new therapies.
Collaborations
Throughout his career, Jagatraj has collaborated with esteemed colleagues, including Bruce Peter Connop and Dorothy Melissa Lynn Spencer. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jagatraj Singh's contributions to the field of diabetes and obesity treatment through his innovative patent work exemplify his commitment to improving healthcare. His ongoing efforts at Eirgen Pharma Ltd. continue to pave the way for advancements in pharmaceutical therapies.